- 4 updates
Drug manufacturers GlaxoSmithKline (GSK) have said their aim is to "minimise further delays" to infants getting access to the meningitis B vaccine.
A spokeswoman for the company, who have taken over the supplying of the vaccine from the original drug company that developed the medicine, said:
Health Secretary Jeremy Hunt has said he is hopeful a deal can be reached "very soon" with the manufacturers of a vaccine that protects children against meningitis.
The Joint Committee on Vaccination and Immunisation recommended the Bexsero MenB vaccine should be made available to children last year.
But the Department of Health has been "in deadlock" with the original drug firm over a cost-effective price for the vaccine.
Campaigners have called for it to be introduced as soon as possible "to save lives".
Mr Hunt said there had been some "real movement" in reaching a fair price since the original drug company that developed the vaccine had been taken over by GSK.
Latest ITV News reports
Harmonie-Rose Allen lost all her limbs after she was struck down with Meningitis B days after taking her first steps at nine months old.
A meningitis vaccine currently at the heart of price negotiations should be introduced as soon as possible "to save lives", it is claimed.